EPIGRAL vs JUBLINGREA: Stock Comparison

Epigral Limited vs Jubilant Ingrevia Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Jubilant Ingrevia Limited is the larger company by market capitalisation. Epigral Limited shows a lower P/E, a higher ROE and faster revenue growth, while Jubilant Ingrevia Limited shows a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Epigral Limited and Jubilant Ingrevia Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, EPIGRAL is more favourable on 9 of 13 scored metrics and JUBLINGREA on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
JUBLINGREA is the larger company
₹11,581 Cr vs ₹5,036 Cr
P/E Ratio
EPIGRAL has a lower P/E
15.04x vs 37.41x
P/B Ratio
EPIGRAL has a lower P/B
2.25x vs 3.69x
EPS
EPIGRAL has higher earnings per share
₹75.27 vs ₹18.39
Dividend Yield
JUBLINGREA has a higher dividend yield
0.7% vs 0.43%
Revenue Growth (TTM YoY)
EPIGRAL has faster revenue growth
17.3% vs 12.1%
EPS Growth (TTM YoY)
JUBLINGREA has faster EPS growth
16.1% vs -6.8%
Qtr Sales Growth
EPIGRAL has stronger quarterly sales growth
17.3% vs 12.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricEPIGRALJUBLINGREA
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricEPIGRALJUBLINGREA
Live Price₹1,162.7₹725.55
Day Change0.93%-2.62%
Volume3.02 L3.73 L
52-Week High₹2,114₹845.55
52-Week Low₹807₹537.3
Distance from 52W High-45%-14.19%

Valuation

MetricEPIGRALJUBLINGREA
Market Cap₹5,036 Cr₹11,581 Cr
P/E Ratio15.04x37.41x
P/B Ratio2.25x3.69x
EPS₹75.27₹18.39
Book Value₹514.92₹197.83
Dividend Yield0.43%0.7%

Growth

MetricEPIGRALJUBLINGREA
Revenue Growth (TTM YoY)17.3%12.1%
EPS Growth (TTM YoY)-6.8%16.1%
Qtr Sales Growth17.3%12.1%
Qtr Profit Growth-6.84%16.7%

Profitability & Leverage

MetricEPIGRALJUBLINGREA
ROE16%9.51%
ROCE15.5%11.4%
Net Margin13.14%6.61%
Operating Margin22.4%12.9%
Debt to Equity0.26x0.25x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricEPIGRALJUBLINGREA
Promoter Holding68.83%41.7%
FII Holding1.03% 0.51 pp6.49%
DII Holding5.56% 0.66 pp24.98% 0.22 pp
Public Holding24.55% 0.15 pp22.29% 0.23 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Epigral Limited and Jubilant Ingrevia Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.